{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:57:38Z","timestamp":1794016658149,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573698"],"award-info":[{"award-number":["81573698"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017696","name":"Hebei Province Graduate Innovation Funding Project","doi-asserted-by":"publisher","award":["XCXZZBS2019005"],"award-info":[{"award-number":["XCXZZBS2019005"]}],"id":[{"id":"10.13039\/501100017696","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.biopha.2020.110071","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:25:58Z","timestamp":1583972758000},"page":"110071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"special_numbering":"C","title":["Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4\/MyD88\/NF-\u03baB signaling pathway"],"prefix":"10.1016","volume":"126","author":[{"given":"Geng-Rui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Huan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-ting","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.110071_bib0005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2020.110071_bib0010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/10408363.2018.1460576","article-title":"Novel heart failure biomarkers: why do we fail to exploit their potential?","volume":"55","author":"Piek","year":"2018","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.biopha.2020.110071_bib0015","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4049\/jimmunol.1900148","article-title":"Phosphatase PPM1L prevents excessive inflammatory responses and cardiac dysfunction after myocardial infarction by inhibiting IKK\u03b2 activation","volume":"203","author":"Wang","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2020.110071_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109514","article-title":"Tongguan capsule derived-herb ameliorates remodeling at infarcted border zone and reduces ventricular arrhythmias in rats after myocardial infarction","volume":"120","author":"Ma","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2020.110071_bib0025","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1042\/CS20170145","article-title":"A role for galectin-3 in the development of early molecular alterations in short-term aortic stenosis","volume":"131","author":"Arrieta","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.biopha.2020.110071_bib0030","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","article-title":"Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension","volume":"66","author":"Mart\u00ednez-Mart\u00ednez","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2020.110071_bib0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jash.2017.03.008","article-title":"Galectin-3 mediates the pulmonary arterial hypertension\u2013induced right ventricular remodeling through interacting with NADPH oxidase 4","volume":"11","author":"He","year":"2017","journal-title":"J. Am. Soc. Hypertens."},{"key":"10.1016\/j.biopha.2020.110071_bib0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijcard.2017.12.103","article-title":"A role for fumarate hydratase in mediating oxidative effects of galectin-3 in human cardiac fibroblasts","volume":"258","author":"Ibarrola","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2020.110071_bib0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cca.2015.10.034","article-title":"Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction","volume":"452","author":"van der Velde","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2020.110071_bib0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/heartjnl-2016-309673","article-title":"Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention","volume":"103","author":"Di Tano","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.biopha.2020.110071_bib0055","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.jacc.2019.02.046","article-title":"Galectin-3 levels and outcomes after myocardial infarction: a population-based study","volume":"73","author":"Asleh","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2020.110071_bib0060","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-065X.2009.00794.x","article-title":"The regulation of inflammation by galectin-3","volume":"230","author":"Henderson","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2020.110071_bib0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cellimm.2015.01.017","article-title":"Downregulating galectin-3 inhibits proinflammatory cytokine production by human monocyte-derived dendritic cells via RNA interference","volume":"294","author":"Chen","year":"2015","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.biopha.2020.110071_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-4461-z","article-title":"Galectin-3 activates TLR4\/NF-KB signaling to promote lung adenocarcinoma cell proliferation through activating lncRNA-NEAT1 expression","volume":"18","author":"Zhou","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2020.110071_bib0075","doi-asserted-by":"crossref","first-page":"10195","DOI":"10.1002\/jcb.28304","article-title":"Galectin-3 deficiency protects lipopolysaccharide-induced chondrocytes injury via regulation of TLR4 and PPAR-\u03b3-mediated NF-\u03baB signaling pathway","volume":"120","author":"Wang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2020.110071_bib0080","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1159\/000490866","article-title":"Effects of the TLR4\/Myd88\/NF-\u03baB signaling pathway on NLRP3 inflammasome in coronary microembolization-induced myocardial injury","volume":"47","author":"Su","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2020.110071_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu11112619","article-title":"Pleiotropic effects of modified citrus pectin","volume":"11","author":"Eliaz","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2020.110071_bib0090","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HYPERTENSIONAHA.115.06161","article-title":"Inhibition of galectin-3 pathway prevents isoproterenol-induced left ventricular dysfunction and fibrosis in mice","volume":"67","author":"Vergaro","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2020.110071_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0166272","article-title":"Galectin-3 blockade reduces renal fibrosis in two normotensive experimental models of renal damage","volume":"11","author":"Martinez-Martinez","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.110071_bib0100","doi-asserted-by":"crossref","first-page":"e18683","DOI":"10.1371\/journal.pone.0018683","article-title":"Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury","volume":"6","author":"Kolatsi-Joannou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.110071_bib0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/HJH.0000000000001545","article-title":"Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats","volume":"36","author":"Mart\u00ednez-Mart\u00ednez","year":"2018","journal-title":"J. Hypertens."},{"key":"10.1016\/j.biopha.2020.110071_bib0110","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1139\/cjpp-2015-0284","article-title":"Modified citrus pectin stops progression of liver fibrosis by inhibiting galectin-3 and inducing apoptosis of stellate cells","volume":"94","author":"Abu-Elsaad","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110071_bib0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2020.110071_bib0120","first-page":"1","article-title":"Perindopril and a galectin-3 inhibitor improve ischemic heart failure in rabbits by reducing gal-3 expression and myocardial fibrosis","volume":"10","author":"Li","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2020.110071_bib0125","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.1038\/s41598-019-46119-6","article-title":"Myocardial injury after ischemia\/reperfusion is attenuated by pharmacological galectin-3 inhibition","volume":"9","author":"Ibarrola","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2020.110071_bib0130","doi-asserted-by":"crossref","first-page":"15611","DOI":"10.3390\/molecules191015611","article-title":"Anti-fibrosis effect of scutellarin via inhibition of endothelial-mesenchymal transition on isoprenaline-induced myocardial fibrosis in rats","volume":"19","author":"Zhou","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2020.110071_bib0135","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejphar.2018.06.016","article-title":"Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome","volume":"833","author":"Wan","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110071_bib0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","article-title":"The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries","volume":"3","author":"Calvier","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.biopha.2020.110071_bib0145","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0002-8703(97)70173-X","article-title":"Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management","volume":"133","author":"Massie","year":"1997","journal-title":"Am. Heart J."},{"key":"10.1016\/j.biopha.2020.110071_bib0150","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the European society of cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2020.110071_bib0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijcard.2019.08.040","article-title":"Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction","volume":"296","author":"Vergaro","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2020.110071_bib0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0002-9149(02)02460-8","article-title":"Thresholds for the electrocardiographic change range of biochemical markers of acute myocardial infarction (GUSTO-IIa Data)","volume":"90","author":"Bahit","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.biopha.2020.110071_bib0165","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2010.06.065","article-title":"Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation","volume":"644","author":"Patel","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110071_bib0170","doi-asserted-by":"crossref","first-page":"H45","DOI":"10.1152\/ajpheart.00609.2018","article-title":"Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced mst1 signaling","volume":"316","author":"Nguyen","year":"2019","journal-title":"Am. J. Physiol. - Hear. Circ. Physiol."},{"key":"10.1016\/j.biopha.2020.110071_bib0175","doi-asserted-by":"crossref","first-page":"L784","DOI":"10.1152\/ajplung.00186.2018","article-title":"Galectin-3 is expressed in vascular smooth muscle cells and promotes pulmonary hypertension through changes in proliferation, apoptosis, and fibrosis","volume":"316","author":"Barman","year":"2019","journal-title":"Am. J. Physiol. - Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.biopha.2020.110071_bib0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0008-6363(97)00212-5","article-title":"Development of heart failure following isoproterenol administration in the rat: Role of the renin-angiotensin system","volume":"37","author":"Grimm","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2020.110071_bib0185","first-page":"1","article-title":"Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.110071_bib0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchf.2014.07.015","article-title":"Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33\/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction","volume":"3","author":"Lax","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.biopha.2020.110071_bib0195","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1159\/000464125","article-title":"Anti-fibrosis effect of relaxin and spironolactone combined on isoprenaline-induced myocardial fibrosis in rats via inhibition of endothelial-mesenchymal transition","volume":"41","author":"Cai","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2020.110071_bib0200","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000473702","article-title":"The inhibitory effect of eplerenone on cell proliferation in the contralateral kidneys of rats with unilateral ureteral obstruction","volume":"136","author":"Wang","year":"2017","journal-title":"Nephron"},{"key":"10.1016\/j.biopha.2020.110071_bib0205","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ajpath.2015.12.017","article-title":"Myocardial galectin-3 expression is associated with remodeling of the pressure-overloaded heart and may delay the hypertrophic response without affecting survival, dysfunction, and cardiac fibrosis","volume":"186","author":"Frunza","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2020.110071_bib0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2015.01.016","article-title":"Galectin-3 is a sensor-regulator of toll-like receptor pathways in synovial fibroblasts","volume":"73","author":"Arad","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2020.110071_bib0215","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.celrep.2015.02.012","article-title":"Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation","volume":"10","author":"Burguillos","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2020.110071_bib0220","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2174\/1381612824666180614090224","article-title":"Toll-like receptors signaling pathways as a potential therapeutic target in cardiovascular disease","volume":"24","author":"Parizadeh","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2020.110071_bib0225","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-\u03baB by toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biopha.2020.110071_bib0230","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/abbs\/gmz009","article-title":"Anti-Toll-like receptor 2 antibody inhibits nuclear factor kappa B activation and attenuates cardiac damage in high-fat-feeding rats","volume":"51","author":"Wang","year":"2019","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)."},{"key":"10.1016\/j.biopha.2020.110071_bib0235","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.freeradbiomed.2012.05.011","article-title":"Aldosterone, oxidative stress, and NF-\u03baB activation in hypertension-related cardiovascular and renal diseases","volume":"53","author":"Queisser","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2020.110071_bib0240","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/HYPERTENSIONAHA.118.11463","article-title":"Association between inflammatory markers and myocardial fibrosis the mesa","volume":"72","author":"Marques","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2020.110071_bib0245","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jjcc.2018.05.010","article-title":"Critical roles of inflammation in atherosclerosis","volume":"73","author":"Moriya","year":"2019","journal-title":"J. Cardiol."},{"key":"10.1016\/j.biopha.2020.110071_bib0250","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00059-019-4788-5","article-title":"Critical inflammatory mechanisms underlying arrhythmias","volume":"44","author":"Vonderlin","year":"2019","journal-title":"Herz"},{"key":"10.1016\/j.biopha.2020.110071_bib0255","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00059-019-4785-8","article-title":"Key inflammatory mechanisms underlying heart failure","volume":"44","author":"Riehle","year":"2019","journal-title":"Herz"},{"key":"10.1016\/j.biopha.2020.110071_bib0260","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-017-0660-3","article-title":"Role of inflammation in heart failure","author":"Shirazi","year":"2017","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.biopha.2020.110071_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.02315","article-title":"Immunity, inflammation and heart failure: their role on cardiac function and iron status","volume":"10","author":"Perticone","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2020.110071_bib0270","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.ircmb.2017.07.007","article-title":"NF-\u03baB and the transcriptional control of inflammation","volume":"335","author":"Mitchell","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2020.110071_bib0275","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2119\/molmed.2014.00034","article-title":"Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure","volume":"20","author":"O\u2019Brien","year":"2014","journal-title":"Mol. Med."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220302626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220302626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:51:53Z","timestamp":1762311113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220302626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":55,"alternative-id":["S0753332220302626"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110071","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4\/MyD88\/NF-\u03baB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110071"}}